Insights

Gathering insights about OCP…

Similar companies to OCP

OCP Tech Stack

OCP uses 8 technology products and services including Google Analytics, Power BI, Jenkins, and more. Explore OCP's tech stack below.

Google Analytics
Analytics
Power BI
Business Intelligence
Jenkins
Continuous Integration
AngularJS
Javascript Frameworks
Angular
Javascript Frameworks
Modernizr
Javascript Libraries
HubSpot Chat
Live Chat
Linux
Programming Languages

Media & News

Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday.
Dec 31, 2024 | www.benzinga.com
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
BOTHELL, Wash., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces plans to extend enrollment in the Phase 2a human challenge study with its investigational, broad-spectrum, oral influenza PB2 inhibitor CDI-42344 due to unexpectedly low influenza infection among study participants who were challenged with a H3N2 viral strain. This randomized, double-blind, placebo-controlled Phase 2a study is evaluating the safety, tolerability, pharmacokinetics (PK), antiviral activity and clinical measurements of CC-42344 at a single site in the United Kingdom.
Dec 31, 2024 | www.globenewswire.com
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences
BOTHELL, Wash., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .'s (Nasdaq: COCP) management announces its participation in the upcoming Virtual Investor Summit Microcap Forum in August and the H.C. Wainwright 26th Annual Global Investment Conference in September.
Aug 19, 2024 | www.globenewswire.com
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day.
Aug 15, 2024 | www.accesswire.com
Cocrystal Pharma, Inc. (COCP) Now Trades Above Golden Cross: Time to Buy?
After reaching an important support level, Cocrystal Pharma, Inc. (COCP) could be a good stock pick from a technical perspective. COCP recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Jun 07, 2024 | www.zacks.com
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
BOTHELL, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three months ended March 31, 2024, and provides updates on its antiviral product pipeline, upcoming milestones and business activities.
May 13, 2024 | www.globenewswire.com
Enrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human challenge clinical study evaluating the safety, tolerability, antiviral and clinical measurements of its novel, broad-spectrum, oral PB2 inhibitor CC-42344. CC-42344 is a new class of antiviral treatment designed to effectively block an essential step in the viral replication and transcription of pandemic and seasonal influenza A, and was discovered using the Company's proprietary structure-based drug discovery platform technology.
May 01, 2024 | www.globenewswire.com

OCP's Email Address Formats

OCP uses at least 1 format(s):

OCP Email Formats	Example	Percentage
FirstL@ocp.org	JohnD@ocp.org	99%
LastF@ocp.org	DoeJ@ocp.org	1%

Frequently Asked Questions

Where is OCP's headquarters located?

OCP's main headquarters is located at 340 Oswego Pointe Dr Lake Oswego, Oregon 97034 US. The company has employees across 6 continents, including AfricaNorth AmericaEurope.

What is OCP's phone number?

You can contact OCP's main corporate office by phone at

+1-877-596-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OCP's stock symbol?

OCP is a publicly traded company; the company's stock symbol is COCP.

What is OCP's official website and social media links?

OCP's official website is ocp.org and has social profiles on LinkedIn.

How much revenue does OCP generate?

As of November 2024, OCP's annual revenue reached $35M.

What is OCP's NAICS code?

OCP's NAICS code is 511 - Publishing Industries (except Internet).

How many employees does OCP have currently?

As of November 2024, OCP has approximately 754 employees across 6 continents, including AfricaNorth AmericaEurope. Key team members include Chief Executive Officer: B. S.CFO: A. R.Chief Financial Officer: H. D.. Explore OCP's employee directory with LeadIQ.

What industry does OCP belong to?

OCP operates in the Book and Periodical Publishing industry.

What technology does OCP use?

OCP's tech stack includes Google AnalyticsPower BIJenkinsAngularJSAngularModernizrHubSpot ChatLinux.

What is OCP's email format?

OCP's email format typically follows the pattern of . Find more OCP email formats with LeadIQ.

When was OCP founded?

OCP was founded in 1928.

OCP

Book and Periodical PublishingOregon, United States501-1000 Employees

OCP (Oregon Catholic Press) is a not-for-profit publisher of liturgical music and worship resources, offering missals, hymnals, liturgical planning tools, parish events, CDs and more. We help our customers address changing needs with innovative solutions that engage, unite and inspire their community in worship. OCP is the premier source for worship aids and is known for its excellent customer service.